Back to dashboard
CommercialCoverageMedium impact

Osseointegration for Lower and Upper Limbs (CPB 1045, reviewed 2026-01-20)

Aetna·Orthopedics, General Surgery, PM&R (Physical Medicine & Rehab) +1 more·Medical Policy
Effective date
Jan 20, 2026
We identified it
Aug 13, 2026
Days to comply

Summary

Aetna has classified osseointegration surgery and prostheses for lower and upper limbs (including OPRA Implant System and Axor II devices) as experimental, investigational, or unproven and does NOT cover these procedures. Billing teams must deny all claims for osseointegration procedures and HCPCS code L5991, and ensure providers understand this is non-covered. Standard Written Orders (SWO) requirements apply if any related DME is billed.

Action Required

Action needed
Effective immediately (2026-01-20): (1) Billing team must update Aetna claim denial logic to automatically deny all claims for osseointegration surgery, OPRA Implant System, Axor II connection device, and HCPCS code L5991 with denial reason 'Experimental/Investigational/Unproven.' (2) Update provider communication materials and billing guides to clearly state that osseointegration for limbs is not covered by Aetna. (3) Front desk and authorization staff must be trained to inform patients and providers upfront that this procedure is non-covered to prevent claim denials and patient financial liability. (4) Providers must document in the medical record that Standard Written Orders (SWO) requirements per DME MAC policy apply if any related osseointegrated prosthetic components are submitted; claims without completed SWO will be denied. (5) Verify that billing software reflects that CPT codes for osseointegration surgery and HCPCS codes for osseoanchored prostheses are not covered. Failure to implement denial rules will result in improper claims processing and potential overpayments.

Affected Billing Codes

L5991